10 Stocks with Strong Buy Signals & High Scores — September 2026

OpportunityRadar Uncovers 10 Strong Buy Signals for September 2026

As September 2026 begins, OpportunityRadar's daily scan has flagged a compelling list of stocks exhibiting strong technical and fundamental indicators. Leading this selection is Zymeworks Inc. (ZYME), which registered an OpportunityRadar Score of 65 – the highest on today's scan – alongside a rare 100% confidence BUY signal and a 'STRONG ENTRY' recommendation. ZYME also demonstrated robust recent performance with a 26.81% return over the last month.

Today's scan reveals a landscape dominated by BUY signals, with all 10 profiled tickers receiving either a 'STRONG ENTRY' or 'ENTRY' recommendation. Among these, three companies – Zymeworks Inc. (ZYME), ScanSource, Inc. (SCSC), and Merck & Company, Inc. (MRK) – stand out with a 100% confidence rating on their BUY signals. The average Relative Strength Index (RSI) across these top 10 tickers hovers around 59.8, indicating generally healthy price momentum without significant overbought conditions, though several tickers show MACD in BEAR territory despite their BUY signals.

Top 10 Signals at a Glance

#1: ZYME — Zymeworks Inc.

Zymeworks Inc. (ZYME) presents a robust profile today, earning the highest OpportunityRadar Score of 65, comprising a technical score of 71 and a fundamental score of 56. The system issued a 'BUY' signal with a maximum confidence level of 100% and a 'STRONG ENTRY' recommendation. Technical indicators show a Relative Strength Index (RSI) at 64.5, indicating strong buying interest, further supported by a MACD in BULL territory. The stock has demonstrated significant positive momentum, with a 1-month return of 26.81% and a 3-month return of 18.73%.

Despite the strong BUY signal and high confidence, ZYME's Risk/Reward ratio stands at 0.5. This low ratio suggests that the potential reward for taking on additional risk might be limited based on the scanner's current parameters. Investors should consider this numerical relationship when evaluating the 'STRONG ENTRY' recommendation.

#2: A — Agilent Technologies, Inc.

Agilent Technologies, Inc. (A) also registered a high OpportunityRadar Score of 65, with technicals at 70 and fundamentals at 58. The system indicates a 'BUY' signal with an 83% confidence level and a 'STRONG ENTRY' recommendation. The stock's RSI is at 52.4, suggesting neutral to slightly positive momentum. Over the past month, Agilent has seen a 6.07% return, extending its 3-month gain to 8.17%. The Risk/Reward ratio for Agilent is 1.1, indicating a balanced risk-return profile.

A notable technical divergence for Agilent is its MACD, which is currently in BEAR territory despite the overall 'BUY' signal. This suggests that while other factors contribute to the strong entry recommendation, the short-term momentum indicated by MACD may be declining, a point for close observation.

#3: VCTR — Victory Capital Holdings, Inc.

Victory Capital Holdings, Inc. (VCTR) comes in with an OpportunityRadar Score of 64, driven by a technical score of 70 and a fundamental score of 56. A 'BUY' signal with 83% confidence and a 'STRONG ENTRY' is noted. The RSI for VCTR is 51.3, indicating a neutral momentum. The stock has experienced a significant 25.67% return over the last three months, with a 1-month return of 11.59%. The Risk/Reward ratio is 1.0, suggesting an equal balance between potential risk and reward.

Similar to Agilent, Victory Capital Holdings shows its MACD in BEAR territory. This technical indicator suggests that recent price action might be showing signs of weakness or consolidation, which contrasts with the 'STRONG ENTRY' signal and warrants careful monitoring of its short-term trend.

#4: RGEN — Repligen Corporation

Repligen Corporation (RGEN) received an OpportunityRadar Score of 64, with its technical score at 69 and fundamental score at 56. The system generated a 'BUY' signal with 83% confidence and a 'STRONG ENTRY' indication. RGEN's RSI stands at 52.7, reflecting a neutral momentum condition. The stock has delivered substantial returns, with a 3-month gain of 33.39% and a 1-month return of 6.44%. The Risk/Reward ratio is 1.2, which is slightly favorable.

Despite the 'STRONG ENTRY' signal, Repligen's MACD is in BEAR territory. This technical aspect suggests that while the overall setup is positive, the immediate price trend may be experiencing downward pressure or a lack of strong upward conviction, creating a potential point of caution for new entries.

#5: NTNX — Nutanix, Inc.

Nutanix, Inc. (NTNX) is highlighted with an OpportunityRadar Score of 64, comprising a technical score of 68 and a fundamental score of 58. The signal for NTNX is 'BUY' with a 67% confidence level and an 'ENTRY' recommendation. The RSI is 62.2, indicating solid positive momentum. Over the past month, NTNX has seen an 11.47% return, contributing to a 23.61% gain over three months. The Risk/Reward ratio for Nutanix is 1.0.

The confidence level for Nutanix's 'BUY' signal is 67%, which is lower than the 83% or 100% seen in other top picks. This, combined with a MACD in BEAR territory despite a relatively high RSI, suggests that while the stock has shown recent strength, the overall conviction for a sustained upward move might be less robust according to the scanner's parameters.

#6: SCSC — ScanSource, Inc.

ScanSource, Inc. (SCSC) earned an OpportunityRadar Score of 63, with its technical score at 69 and fundamental score at 53. The system issued a 'BUY' signal with a 100% confidence level, accompanied by a 'STRONG ENTRY' recommendation. Technical indicators show an RSI of 57.1 and a MACD in BULL territory, suggesting positive momentum. SCSC has delivered a strong 20.11% return over the past three months. Notably, its Risk/Reward ratio is 1.7, indicating a favorable risk-return profile.

A point of consideration for SCSC is its 1-month return, which stands at -0.68%. While the 3-month performance is strong and confidence is at 100%, this recent negative short-term performance might warrant a closer look, despite the bullish MACD and strong overall signal.

#7: PAG — Penske Automotive Group, Inc.

Penske Automotive Group, Inc. (PAG) received an OpportunityRadar Score of 63, with a technical score of 66 and a fundamental score of 58. The signal is a 'BUY' with a 67% confidence level and an 'ENTRY' recommendation. PAG's RSI is 62.1, indicating positive momentum. The stock has seen a 1.89% return over the last month and an impressive 28.1% return over the past three months. Its Risk/Reward ratio is 2.0, which is the highest among the profiled stocks, indicating a potentially attractive reward relative to risk.

Despite the high Risk/Reward ratio, Penske Automotive Group's confidence level is 67%, placing it in the lower tier of today's 'BUY' signals. Additionally, the MACD is in BEAR territory, which could signal a potential short-term pullback or consolidation, contrasting with the positive RSI and 3-month performance.

#8: FDS — FactSet Research Systems Inc.

FactSet Research Systems Inc. (FDS) is identified with an OpportunityRadar Score of 63, consisting of a technical score of 66 and a fundamental score of 58. The system indicates a 'BUY' signal with 83% confidence and a 'STRONG ENTRY' recommendation. FDS exhibits strong technical momentum with an RSI of 64.2 and a MACD in BULL territory. The stock has delivered a 11.69% return in the last month and a 21.76% return over three months.

The Risk/Reward ratio for FactSet Research Systems is 0.3. This is a very low ratio, suggesting that the potential upside from the current entry point may be significantly limited compared to the associated risk, despite the strong technical indicators and high confidence rating.

#9: MRK — Merck & Company, Inc.

Merck & Company, Inc. (MRK) garnered an OpportunityRadar Score of 63, with technicals at 68 and fundamentals at 55. The system issued a 'BUY' signal with a 100% confidence level and a 'STRONG ENTRY' recommendation. Technical analysis shows an RSI of 64.2 and a MACD in BULL territory, both pointing to strong positive momentum. Merck has demonstrated robust performance, with a 1-month return of 17.67% and a 3-month return of 25.56%.

Similar to FDS, Merck & Company's Risk/Reward ratio is 0.4. While the stock shows maximum confidence and strong technicals, this low ratio suggests that the potential reward for new positions might be constrained relative to the risk, a factor to consider alongside its strong recent performance.

#10: BWIN — The Baldwin Insurance Group, I

The Baldwin Insurance Group, I (BWIN) completes our top 10 list with an OpportunityRadar Score of 62, comprising a technical score of 66 and a fundamental score of 56. The signal is 'BUY' with a 67% confidence level and an 'ENTRY' recommendation. BWIN's RSI stands at 57.9, indicating moderate positive momentum. The stock has delivered an impressive 61.17% return over the last three months, with a 7.79% gain in the past month. The Risk/Reward ratio is 0.5.

The Baldwin Insurance Group's 'BUY' signal carries a 67% confidence, which is lower than many other tickers on the list. Furthermore, its MACD is in BEAR territory. This combination of moderate confidence and a bearish MACD suggests that while the stock has shown significant past performance, the immediate technical picture may be less clear or subject to consolidation, despite the overall BUY signal.

Key Observations Across the Scan

• **High Confidence Signals:** Three of the ten profiled tickers—Zymeworks Inc. (ZYME), ScanSource, Inc. (SCSC), and Merck & Company, Inc. (MRK)—received a maximum 100% confidence rating for their BUY signals.
• **Bullish MACD Presence:** Four tickers, Zymeworks Inc. (ZYME), ScanSource, Inc. (SCSC), FactSet Research Systems Inc. (FDS), and Merck & Company, Inc. (MRK), show their MACD in BULL territory, indicating positive short-term momentum.
• **Strong Recent Returns:** Five tickers (ZYME, VCTR, NTNX, FDS, MRK) delivered a 1-month return exceeding 10%, with ZYME leading at 26.81%.
• **Consistent 3-Month Gains:** Eight of the ten tickers achieved a 3-month return greater than 20%, highlighting broad-based strength over the medium term. The Baldwin Insurance Group, I (BWIN) notably leads this category with a 61.17% return.
• **Varied Entry Confidence:** While all signals are 'BUY', confidence levels range from 67% to 100%, indicating differing degrees of alignment across the scanner's confirmation factors.

Key Risk Factors

• **Low Risk/Reward Ratios:** Several tickers exhibit low Risk/Reward ratios, which may indicate limited potential upside relative to the downside risk. Specifically, FactSet Research Systems Inc. (FDS) at 0.3, Merck & Company, Inc. (MRK) at 0.4, Zymeworks Inc. (ZYME) at 0.5, and The Baldwin Insurance Group, I (BWIN) at 0.5 are notable examples.
• **MACD Bearish Divergence:** Despite 'BUY' signals and often 'STRONG ENTRY' recommendations, five of the ten profiled tickers—Agilent Technologies, Inc. (A), Victory Capital Holdings, Inc. (VCTR), Repligen Corporation (RGEN), Nutanix, Inc. (NTNX), Penske Automotive Group, Inc. (PAG), and The Baldwin Insurance Group, I (BWIN)—show their MACD in BEAR territory. This divergence between the overall signal and short-term momentum indicator warrants close monitoring.
• **Negative Short-Term Performance:** ScanSource, Inc. (SCSC), despite its 100% confidence 'STRONG ENTRY' signal, recorded a -0.68% return over the past month. While its 3-month return is positive, this recent dip could indicate short-term weakness.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of September 03, 2026.